nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—Clotting—Octreotide—thymus cancer	0.0181	0.0283	CcSEcCtD
Tretinoin—Ischaemia—Octreotide—thymus cancer	0.0177	0.0277	CcSEcCtD
Tretinoin—GPRC5A—lung—thymus cancer	0.0166	0.0458	CbGeAlD
Tretinoin—VIIth nerve paralysis—Octreotide—thymus cancer	0.0157	0.0247	CcSEcCtD
Tretinoin—CRABP1—neck—thymus cancer	0.0143	0.0396	CbGeAlD
Tretinoin—Pancreatitis acute—Octreotide—thymus cancer	0.014	0.0219	CcSEcCtD
Tretinoin—Creatine phosphokinase increased—Octreotide—thymus cancer	0.0123	0.0192	CcSEcCtD
Tretinoin—Ear disorder—Octreotide—thymus cancer	0.012	0.0187	CcSEcCtD
Tretinoin—Local reaction—Octreotide—thymus cancer	0.0117	0.0183	CcSEcCtD
Tretinoin—Pregnancy—Octreotide—thymus cancer	0.0114	0.0178	CcSEcCtD
Tretinoin—RXRG—neck—thymus cancer	0.0113	0.0313	CbGeAlD
Tretinoin—ALDH1A2—hematopoietic system—thymus cancer	0.0111	0.0306	CbGeAlD
Tretinoin—Gastrointestinal symptom NOS—Octreotide—thymus cancer	0.011	0.0172	CcSEcCtD
Tretinoin—RARRES1—cardiac atrium—thymus cancer	0.011	0.0303	CbGeAlD
Tretinoin—ALDH1A1—neck—thymus cancer	0.0108	0.0299	CbGeAlD
Tretinoin—RARRES1—pituitary gland—thymus cancer	0.0107	0.0296	CbGeAlD
Tretinoin—CRABP1—hematopoietic system—thymus cancer	0.0107	0.0295	CbGeAlD
Tretinoin—Nail disorder—Octreotide—thymus cancer	0.00996	0.0156	CcSEcCtD
Tretinoin—Redness—Octreotide—thymus cancer	0.00957	0.015	CcSEcCtD
Tretinoin—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.00947	0.0148	CcSEcCtD
Tretinoin—Menstrual disorder—Octreotide—thymus cancer	0.00947	0.0148	CcSEcCtD
Tretinoin—Blood creatine phosphokinase increased—Octreotide—thymus cancer	0.00938	0.0147	CcSEcCtD
Tretinoin—RARRES1—thyroid gland—thymus cancer	0.00923	0.0255	CbGeAlD
Tretinoin—NR0B1—pituitary gland—thymus cancer	0.00921	0.0255	CbGeAlD
Tretinoin—RARRES1—lung—thymus cancer	0.00838	0.0232	CbGeAlD
Tretinoin—Coagulopathy—Octreotide—thymus cancer	0.00829	0.013	CcSEcCtD
Tretinoin—ALDH1A2—pituitary gland—thymus cancer	0.00821	0.0227	CbGeAlD
Tretinoin—ALDH1A1—hematopoietic system—thymus cancer	0.00805	0.0222	CbGeAlD
Tretinoin—Tingling sensation—Octreotide—thymus cancer	0.00803	0.0126	CcSEcCtD
Tretinoin—Stinging—Octreotide—thymus cancer	0.00797	0.0125	CcSEcCtD
Tretinoin—CRABP1—pituitary gland—thymus cancer	0.00792	0.0219	CbGeAlD
Tretinoin—Numbness—Octreotide—thymus cancer	0.00779	0.0122	CcSEcCtD
Tretinoin—Acne—Octreotide—thymus cancer	0.00767	0.012	CcSEcCtD
Tretinoin—Neoplasm malignant—Octreotide—thymus cancer	0.00756	0.0119	CcSEcCtD
Tretinoin—Sensory loss—Octreotide—thymus cancer	0.00745	0.0117	CcSEcCtD
Tretinoin—Contusion—Octreotide—thymus cancer	0.0074	0.0116	CcSEcCtD
Tretinoin—NR0B1—lung—thymus cancer	0.00721	0.0199	CbGeAlD
Tretinoin—CRABP2—pituitary gland—thymus cancer	0.00716	0.0198	CbGeAlD
Tretinoin—Rectal haemorrhage—Octreotide—thymus cancer	0.00715	0.0112	CcSEcCtD
Tretinoin—Cellulitis—Octreotide—thymus cancer	0.0071	0.0111	CcSEcCtD
Tretinoin—ALDH1A2—thyroid gland—thymus cancer	0.00708	0.0196	CbGeAlD
Tretinoin—RARG—hematopoietic system—thymus cancer	0.00705	0.0195	CbGeAlD
Tretinoin—Herpes simplex—Octreotide—thymus cancer	0.00701	0.011	CcSEcCtD
Tretinoin—Drug interaction—Octreotide—thymus cancer	0.00696	0.0109	CcSEcCtD
Tretinoin—CRABP1—thyroid gland—thymus cancer	0.00683	0.0189	CbGeAlD
Tretinoin—Hearing impaired—Octreotide—thymus cancer	0.00678	0.0106	CcSEcCtD
Tretinoin—RARA—hematopoietic system—thymus cancer	0.00662	0.0183	CbGeAlD
Tretinoin—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00646	0.0101	CcSEcCtD
Tretinoin—ALDH1A2—lung—thymus cancer	0.00643	0.0178	CbGeAlD
Tretinoin—Injection site reaction—Octreotide—thymus cancer	0.00642	0.0101	CcSEcCtD
Tretinoin—Cystitis noninfective—Octreotide—thymus cancer	0.00631	0.00988	CcSEcCtD
Tretinoin—Wheezing—Octreotide—thymus cancer	0.00627	0.00983	CcSEcCtD
Tretinoin—RXRG—pituitary gland—thymus cancer	0.00626	0.0173	CbGeAlD
Tretinoin—Cystitis—Octreotide—thymus cancer	0.00624	0.00977	CcSEcCtD
Tretinoin—CRABP2—thyroid gland—thymus cancer	0.00618	0.0171	CbGeAlD
Tretinoin—Candida infection—Octreotide—thymus cancer	0.00616	0.00966	CcSEcCtD
Tretinoin—ALDH1A1—cardiac atrium—thymus cancer	0.00611	0.0169	CbGeAlD
Tretinoin—RXRB—cardiac atrium—thymus cancer	0.00603	0.0167	CbGeAlD
Tretinoin—ALDH1A1—pituitary gland—thymus cancer	0.00597	0.0165	CbGeAlD
Tretinoin—Bladder pain—Octreotide—thymus cancer	0.00584	0.00915	CcSEcCtD
Tretinoin—Mouth ulceration—Octreotide—thymus cancer	0.00584	0.00915	CcSEcCtD
Tretinoin—RARRES1—lymph node—thymus cancer	0.00573	0.0158	CbGeAlD
Tretinoin—ALDH1A1—lymphoid tissue—thymus cancer	0.00567	0.0157	CbGeAlD
Tretinoin—CRABP2—lung—thymus cancer	0.00561	0.0155	CbGeAlD
Tretinoin—RARB—thyroid gland—thymus cancer	0.00552	0.0153	CbGeAlD
Tretinoin—Phlebitis—Octreotide—thymus cancer	0.00544	0.00853	CcSEcCtD
Tretinoin—RXRG—thyroid gland—thymus cancer	0.0054	0.0149	CbGeAlD
Tretinoin—Diabetes mellitus—Octreotide—thymus cancer	0.00539	0.00844	CcSEcCtD
Tretinoin—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00539	0.00844	CcSEcCtD
Tretinoin—Deafness—Octreotide—thymus cancer	0.00524	0.00821	CcSEcCtD
Tretinoin—Cardiac failure congestive—Octreotide—thymus cancer	0.00517	0.0081	CcSEcCtD
Tretinoin—ALDH1A1—bone marrow—thymus cancer	0.00516	0.0143	CbGeAlD
Tretinoin—ALDH1A1—thyroid gland—thymus cancer	0.00515	0.0142	CbGeAlD
Tretinoin—Nasal congestion—Octreotide—thymus cancer	0.00515	0.00806	CcSEcCtD
Tretinoin—RXRB—thyroid gland—thymus cancer	0.00508	0.014	CbGeAlD
Tretinoin—RARB—lung—thymus cancer	0.00502	0.0139	CbGeAlD
Tretinoin—Visual disturbance—Octreotide—thymus cancer	0.00495	0.00775	CcSEcCtD
Tretinoin—RARA—pituitary gland—thymus cancer	0.00491	0.0136	CbGeAlD
Tretinoin—Arthritis—Octreotide—thymus cancer	0.00482	0.00756	CcSEcCtD
Tretinoin—Pain in extremity—Octreotide—thymus cancer	0.00469	0.00735	CcSEcCtD
Tretinoin—Osteoarthritis—Octreotide—thymus cancer	0.00469	0.00735	CcSEcCtD
Tretinoin—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00469	0.00735	CcSEcCtD
Tretinoin—ALDH1A1—lung—thymus cancer	0.00467	0.0129	CbGeAlD
Tretinoin—RARA—lymphoid tissue—thymus cancer	0.00466	0.0129	CbGeAlD
Tretinoin—RXRB—lung—thymus cancer	0.00461	0.0127	CbGeAlD
Tretinoin—Psychotic disorder—Octreotide—thymus cancer	0.00458	0.00717	CcSEcCtD
Tretinoin—RARG—thyroid gland—thymus cancer	0.00451	0.0124	CbGeAlD
Tretinoin—Irritability—Octreotide—thymus cancer	0.00447	0.00701	CcSEcCtD
Tretinoin—ALDH1A2—lymph node—thymus cancer	0.0044	0.0122	CbGeAlD
Tretinoin—Dehydration—Octreotide—thymus cancer	0.00436	0.00683	CcSEcCtD
Tretinoin—Dry skin—Octreotide—thymus cancer	0.0043	0.00673	CcSEcCtD
Tretinoin—RARA—bone marrow—thymus cancer	0.00425	0.0117	CbGeAlD
Tretinoin—RARA—thyroid gland—thymus cancer	0.00424	0.0117	CbGeAlD
Tretinoin—Nasopharyngitis—Octreotide—thymus cancer	0.00419	0.00657	CcSEcCtD
Tretinoin—Gastritis—Octreotide—thymus cancer	0.00415	0.0065	CcSEcCtD
Tretinoin—RARG—lung—thymus cancer	0.00409	0.0113	CbGeAlD
Tretinoin—Abdominal distension—Octreotide—thymus cancer	0.00408	0.00639	CcSEcCtD
Tretinoin—Asthma—Octreotide—thymus cancer	0.00405	0.00635	CcSEcCtD
Tretinoin—Bronchospasm—Octreotide—thymus cancer	0.00398	0.00624	CcSEcCtD
Tretinoin—Pancreatitis—Octreotide—thymus cancer	0.00397	0.00622	CcSEcCtD
Tretinoin—Sweating increased—Octreotide—thymus cancer	0.00395	0.00618	CcSEcCtD
Tretinoin—Abdominal discomfort—Octreotide—thymus cancer	0.00388	0.00609	CcSEcCtD
Tretinoin—RARA—lung—thymus cancer	0.00385	0.0106	CbGeAlD
Tretinoin—Dysuria—Octreotide—thymus cancer	0.00379	0.00594	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Octreotide—thymus cancer	0.00377	0.0059	CcSEcCtD
Tretinoin—Pollakiuria—Octreotide—thymus cancer	0.00374	0.00586	CcSEcCtD
Tretinoin—Weight increased—Octreotide—thymus cancer	0.00369	0.00578	CcSEcCtD
Tretinoin—Weight decreased—Octreotide—thymus cancer	0.00367	0.00574	CcSEcCtD
Tretinoin—Pneumonia—Octreotide—thymus cancer	0.00363	0.00569	CcSEcCtD
Tretinoin—Drowsiness—Octreotide—thymus cancer	0.00361	0.00566	CcSEcCtD
Tretinoin—Depression—Octreotide—thymus cancer	0.0036	0.00564	CcSEcCtD
Tretinoin—Neuropathy peripheral—Octreotide—thymus cancer	0.00354	0.00555	CcSEcCtD
Tretinoin—Conjunctivitis—Octreotide—thymus cancer	0.00351	0.0055	CcSEcCtD
Tretinoin—Urinary tract infection—Octreotide—thymus cancer	0.00351	0.0055	CcSEcCtD
Tretinoin—Haematuria—Octreotide—thymus cancer	0.00344	0.0054	CcSEcCtD
Tretinoin—RARB—lymph node—thymus cancer	0.00343	0.00948	CbGeAlD
Tretinoin—Epistaxis—Octreotide—thymus cancer	0.00341	0.00534	CcSEcCtD
Tretinoin—Sinusitis—Octreotide—thymus cancer	0.00339	0.00531	CcSEcCtD
Tretinoin—Hepatitis—Octreotide—thymus cancer	0.00324	0.00508	CcSEcCtD
Tretinoin—Hypoaesthesia—Octreotide—thymus cancer	0.00323	0.00506	CcSEcCtD
Tretinoin—Pharyngitis—Octreotide—thymus cancer	0.00322	0.00504	CcSEcCtD
Tretinoin—ALDH1A1—lymph node—thymus cancer	0.0032	0.00883	CbGeAlD
Tretinoin—Oedema peripheral—Octreotide—thymus cancer	0.00319	0.00501	CcSEcCtD
Tretinoin—Visual impairment—Octreotide—thymus cancer	0.00312	0.0049	CcSEcCtD
Tretinoin—Tinnitus—Octreotide—thymus cancer	0.00302	0.00474	CcSEcCtD
Tretinoin—Flushing—Octreotide—thymus cancer	0.00301	0.00472	CcSEcCtD
Tretinoin—Arrhythmia—Octreotide—thymus cancer	0.0029	0.00454	CcSEcCtD
Tretinoin—Alopecia—Octreotide—thymus cancer	0.00287	0.00449	CcSEcCtD
Tretinoin—Mental disorder—Octreotide—thymus cancer	0.00284	0.00445	CcSEcCtD
Tretinoin—Erythema—Octreotide—thymus cancer	0.00282	0.00442	CcSEcCtD
Tretinoin—Malnutrition—Octreotide—thymus cancer	0.00282	0.00442	CcSEcCtD
Tretinoin—RARG—lymph node—thymus cancer	0.0028	0.00773	CbGeAlD
Tretinoin—Flatulence—Octreotide—thymus cancer	0.00278	0.00436	CcSEcCtD
Tretinoin—Tension—Octreotide—thymus cancer	0.00277	0.00434	CcSEcCtD
Tretinoin—Nervousness—Octreotide—thymus cancer	0.00274	0.0043	CcSEcCtD
Tretinoin—Back pain—Octreotide—thymus cancer	0.00273	0.00428	CcSEcCtD
Tretinoin—CYP2A6—lung—thymus cancer	0.00272	0.0075	CbGeAlD
Tretinoin—Vision blurred—Octreotide—thymus cancer	0.00266	0.00417	CcSEcCtD
Tretinoin—Tremor—Octreotide—thymus cancer	0.00264	0.00414	CcSEcCtD
Tretinoin—RARA—lymph node—thymus cancer	0.00263	0.00727	CbGeAlD
Tretinoin—CYP2C8—hematopoietic system—thymus cancer	0.00262	0.00725	CbGeAlD
Tretinoin—Ill-defined disorder—Octreotide—thymus cancer	0.00262	0.0041	CcSEcCtD
Tretinoin—Anaemia—Octreotide—thymus cancer	0.00261	0.00409	CcSEcCtD
Tretinoin—Agitation—Octreotide—thymus cancer	0.00259	0.00407	CcSEcCtD
Tretinoin—Malaise—Octreotide—thymus cancer	0.00255	0.00399	CcSEcCtD
Tretinoin—Syncope—Octreotide—thymus cancer	0.00253	0.00397	CcSEcCtD
Tretinoin—Palpitations—Octreotide—thymus cancer	0.00249	0.00391	CcSEcCtD
Tretinoin—Loss of consciousness—Octreotide—thymus cancer	0.00248	0.00389	CcSEcCtD
Tretinoin—Cough—Octreotide—thymus cancer	0.00246	0.00386	CcSEcCtD
Tretinoin—Convulsion—Octreotide—thymus cancer	0.00245	0.00383	CcSEcCtD
Tretinoin—Hypertension—Octreotide—thymus cancer	0.00244	0.00382	CcSEcCtD
Tretinoin—CYP1A1—hematopoietic system—thymus cancer	0.00242	0.00669	CbGeAlD
Tretinoin—Chest pain—Octreotide—thymus cancer	0.0024	0.00377	CcSEcCtD
Tretinoin—Myalgia—Octreotide—thymus cancer	0.0024	0.00377	CcSEcCtD
Tretinoin—Arthralgia—Octreotide—thymus cancer	0.0024	0.00377	CcSEcCtD
Tretinoin—Anxiety—Octreotide—thymus cancer	0.00239	0.00375	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00239	0.00374	CcSEcCtD
Tretinoin—Discomfort—Octreotide—thymus cancer	0.00237	0.00372	CcSEcCtD
Tretinoin—CYP3A5—hematopoietic system—thymus cancer	0.00237	0.00655	CbGeAlD
Tretinoin—CYP2B6—hematopoietic system—thymus cancer	0.00235	0.00651	CbGeAlD
Tretinoin—Dry mouth—Octreotide—thymus cancer	0.00235	0.00368	CcSEcCtD
Tretinoin—CYP2C9—hematopoietic system—thymus cancer	0.00233	0.00644	CbGeAlD
Tretinoin—Anaphylactic shock—Octreotide—thymus cancer	0.0023	0.00361	CcSEcCtD
Tretinoin—Oedema—Octreotide—thymus cancer	0.0023	0.00361	CcSEcCtD
Tretinoin—Infection—Octreotide—thymus cancer	0.00229	0.00359	CcSEcCtD
Tretinoin—Shock—Octreotide—thymus cancer	0.00227	0.00355	CcSEcCtD
Tretinoin—Nervous system disorder—Octreotide—thymus cancer	0.00226	0.00354	CcSEcCtD
Tretinoin—Thrombocytopenia—Octreotide—thymus cancer	0.00226	0.00353	CcSEcCtD
Tretinoin—Tachycardia—Octreotide—thymus cancer	0.00225	0.00352	CcSEcCtD
Tretinoin—Skin disorder—Octreotide—thymus cancer	0.00224	0.00351	CcSEcCtD
Tretinoin—Hyperhidrosis—Octreotide—thymus cancer	0.00223	0.00349	CcSEcCtD
Tretinoin—CYP1A1—epithelium—thymus cancer	0.00221	0.00612	CbGeAlD
Tretinoin—Anorexia—Octreotide—thymus cancer	0.0022	0.00344	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Octreotide—thymus cancer	0.0021	0.00329	CcSEcCtD
Tretinoin—Insomnia—Octreotide—thymus cancer	0.00208	0.00327	CcSEcCtD
Tretinoin—Paraesthesia—Octreotide—thymus cancer	0.00207	0.00324	CcSEcCtD
Tretinoin—Dyspnoea—Octreotide—thymus cancer	0.00205	0.00322	CcSEcCtD
Tretinoin—Somnolence—Octreotide—thymus cancer	0.00205	0.00321	CcSEcCtD
Tretinoin—Dyspepsia—Octreotide—thymus cancer	0.00203	0.00318	CcSEcCtD
Tretinoin—Decreased appetite—Octreotide—thymus cancer	0.002	0.00314	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Octreotide—thymus cancer	0.00199	0.00312	CcSEcCtD
Tretinoin—Fatigue—Octreotide—thymus cancer	0.00199	0.00311	CcSEcCtD
Tretinoin—Pain—Octreotide—thymus cancer	0.00197	0.00309	CcSEcCtD
Tretinoin—Constipation—Octreotide—thymus cancer	0.00197	0.00309	CcSEcCtD
Tretinoin—CYP2C8—pituitary gland—thymus cancer	0.00195	0.00538	CbGeAlD
Tretinoin—Feeling abnormal—Octreotide—thymus cancer	0.0019	0.00298	CcSEcCtD
Tretinoin—Gastrointestinal pain—Octreotide—thymus cancer	0.00188	0.00295	CcSEcCtD
Tretinoin—CYP1A1—cardiac atrium—thymus cancer	0.00184	0.00508	CbGeAlD
Tretinoin—Urticaria—Octreotide—thymus cancer	0.00183	0.00287	CcSEcCtD
Tretinoin—Body temperature increased—Octreotide—thymus cancer	0.00182	0.00285	CcSEcCtD
Tretinoin—Abdominal pain—Octreotide—thymus cancer	0.00182	0.00285	CcSEcCtD
Tretinoin—CYP3A4—hematopoietic system—thymus cancer	0.00178	0.00491	CbGeAlD
Tretinoin—Hypersensitivity—Octreotide—thymus cancer	0.0017	0.00266	CcSEcCtD
Tretinoin—CYP2B6—lymphoid tissue—thymus cancer	0.00166	0.00458	CbGeAlD
Tretinoin—Asthenia—Octreotide—thymus cancer	0.00165	0.00259	CcSEcCtD
Tretinoin—Pruritus—Octreotide—thymus cancer	0.00163	0.00255	CcSEcCtD
Tretinoin—Diarrhoea—Octreotide—thymus cancer	0.00158	0.00247	CcSEcCtD
Tretinoin—CYP1A1—thyroid gland—thymus cancer	0.00155	0.00428	CbGeAlD
Tretinoin—Dizziness—Octreotide—thymus cancer	0.00152	0.00239	CcSEcCtD
Tretinoin—Vomiting—Octreotide—thymus cancer	0.00146	0.0023	CcSEcCtD
Tretinoin—Rash—Octreotide—thymus cancer	0.00145	0.00228	CcSEcCtD
Tretinoin—Dermatitis—Octreotide—thymus cancer	0.00145	0.00227	CcSEcCtD
Tretinoin—Headache—Octreotide—thymus cancer	0.00144	0.00226	CcSEcCtD
Tretinoin—CYP1A1—lung—thymus cancer	0.00141	0.00389	CbGeAlD
Tretinoin—CYP3A5—lung—thymus cancer	0.00138	0.0038	CbGeAlD
Tretinoin—Nausea—Octreotide—thymus cancer	0.00137	0.00214	CcSEcCtD
Tretinoin—CYP2B6—lung—thymus cancer	0.00137	0.00378	CbGeAlD
Tretinoin—CYP1A1—lymph node—thymus cancer	0.000962	0.00266	CbGeAlD
